Call Us Today!
(225) 706-8424

2014 Performance

 

Accountable Care Organization 2014 Quality Performance Summary Statistics Report
TP-ACO L.L.C.
Domain Measure Number Measure Name   TP-ACO Performance Rate  Mean Performance Rate All ACOs 
Patient/Caregiver Experience ACO-1 Getting Timely Care, Appointments, and Information 81.24 80.13
ACO-2 How Well Your Doctors Communicate 94.50 92.39
ACO-3 Patients’ Rating of Doctor 92.50 91.58
ACO-4 Access to Specialists 84.85 83.97
ACO-5 Health Promotion and Education 61.28 58.29
ACO-6 Shared Decision Making 78.16 74.60
ACO-7 Health Status/Functional Status 69.28 71.10
Care Coordination/Patient Safety ACO-8 Risk Standardized, All Condition Readmissions 14.32 15.15
ACO-9 ASC Admissions: COPD or Asthma in Older Adults 1.74 1.08
ACO-10 ASC Admission: HF 1.21 1.19
ACO-11 Percent of Primary Care Providers Who Successfully Attested for the EHR Incentive Program Incentive Payment 59.70% 76.71%
ACO-12 Medication Reconciliation 95.79% 82.61%
ACO-13 Falls: Screening for Fall Risk 64.83% 45.60%
Preventive Health ACO-14 Influenza Immunization 57.38% 57.51%
ACO-15 Pneumococcal Vaccination 52.52% 55.03%
ACO-16 Adult Weight Screening and Follow-up 70.28% 66.75%
ACO-17 Tobacco Use Assessment and Cessation Intervention 82.86% 86.79%
ACO-18 Depression Screening 44.13% 39.27%
ACO-19 Colorectal Cancer Screening 47.28% 56.14%
ACO-20 Mammography Screening 46.47% 61.41%
ACO-21 Proportion of Adults who had blood pressure screened in past 2 years 71.36% 60.24%
At Risk Population Diabetes Composite Beneficiaries with diabetes who met of all the following criteria: 0.00% 25.41%
ACO-22 Hemoglobin A1c Control (HbA1c) (<8 percent) 64.96% 25.41%
ACO-23 Low Density Lipoprotein (LDL) (< 100 mg/dL) 0.00% 25.41%
ACO-24 Blood Pressure (BP) < 140/90 58.39% 25.41%
ACO-25 Tobacco Non-Use 67.88% 25.41%
ACO-26 Aspirin Use 51.89% 25.41%
ACO-27 Percent of beneficiaries with diabetes whose HbA1c in poor control (>9 percent) 27.74% 20.35%
ACO-28 Percent of beneficiaries with hypertension whose BP < 140/90 60.96% 68.02%
ACO-29 Percent of beneficiaries with IVD with complete lipid profile and LDL control < 100mg/dl 48.00% 57.29%
ACO-30 Percent of beneficiaries who use Aspirin or other antithrombotic 75.78% 80.79%
ACO-31 Beta-Blocker Therapy for LVSD 95.83% 82.71%
CAD Composite Percent of beneficiaries with CAD  who met all of the following criteria: 56.45% 66.90%
ACO-32 Drug Therapy for Lowering LDL-Cholesterol 63.02% 66.90%
ACO-33 (ACE) Inhibitor or (ARB) Therapy for Patients with CAD and Diabetes and/or (LVSD) 61.74% 66.90%